Debt-to-equity in % of GALECTIN THERAPEUTICS INC from Q1 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GALECTIN THERAPEUTICS INC quarterly Debt-to-equity history and change rate from Q1 2012 to Q3 2025.
  • GALECTIN THERAPEUTICS INC Debt-to-equity for the quarter ending 30 Sep 2025 was -111 %, a 24.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GALECTIN THERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -111 +36 +24.6% 30 Sep 2025
Q2 2025 -115 +36.7 +24.2% 30 Jun 2025
Q1 2025 -119 +36.3 +23.3% 31 Mar 2025
Q4 2024 -137 +2.41 +1.73% 31 Dec 2024
Q3 2024 -147 -4.67 -3.29% 30 Sep 2024
Q2 2024 -152 -4.88 -3.33% 30 Jun 2024
Q1 2024 -156 +10.1 +6.08% 31 Mar 2024
Q4 2023 -140 +71.3 +33.8% 31 Dec 2023
Q3 2023 -142 +192 +57.5% 30 Sep 2023
Q2 2023 -147 +759 +83.8% 30 Jun 2023
Q1 2023 -166 -946 -121% 31 Mar 2023
Q4 2022 -211 -431 -196% 31 Dec 2022
Q3 2022 -334 -423 -475% 30 Sep 2022
Q2 2022 -906 -940 -2742% 30 Jun 2022
Q1 2022 781 +764 +4713% 31 Mar 2022
Q4 2021 221 +210 +1989% 31 Dec 2021
Q3 2021 89.1 +81.7 +1110% 30 Sep 2021
Q2 2021 34.3 +28.4 +487% 30 Jun 2021
Q1 2021 16.2 +12.4 +329% 31 Mar 2021
Q4 2020 10.6 +6.11 +137% 31 Dec 2020
Q3 2020 7.36 +2.02 +37.8% 30 Sep 2020
Q2 2020 5.84 -3.25 -35.7% 30 Jun 2020
Q1 2020 3.78 -20.4 -84.4% 31 Mar 2020
Q4 2019 4.45 -30.5 -87.3% 31 Dec 2019
Q3 2019 5.34 -47.8 -89.9% 30 Sep 2019
Q2 2019 9.09 -108 -92.3% 30 Jun 2019
Q1 2019 24.1 -217 -90% 31 Mar 2019
Q4 2018 34.9 -87.3 -71.4% 31 Dec 2018
Q3 2018 53.1 -15.7 -22.8% 30 Sep 2018
Q2 2018 117 +69.1 +143% 30 Jun 2018
Q1 2018 241 +197 +447% 31 Mar 2018
Q4 2017 122 +85.8 +236% 31 Dec 2017
Q3 2017 68.8 +43.3 +170% 30 Sep 2017
Q2 2017 48.3 +28.7 +146% 30 Jun 2017
Q1 2017 44.1 +30.6 +227% 31 Mar 2017
Q4 2016 36.4 +27.5 +309% 31 Dec 2016
Q3 2016 25.5 +16.6 +184% 30 Sep 2016
Q2 2016 19.6 +12.2 +163% 30 Jun 2016
Q1 2016 13.5 +6.38 +90% 31 Mar 2016
Q4 2015 8.9 +1.62 +22.2% 31 Dec 2015
Q3 2015 8.99 -1.12 -11.1% 30 Sep 2015
Q2 2015 7.47 -6.93 -48.1% 30 Jun 2015
Q1 2015 7.09 -19.8 -73.7% 31 Mar 2015
Q4 2014 7.28 +533 31 Dec 2014
Q3 2014 10.1 +385 30 Sep 2014
Q2 2014 14.4 -6.23K -99.8% 30 Jun 2014
Q1 2014 26.9 -51.4 -65.6% 31 Mar 2014
Q4 2013 -525 -569 -1297% 31 Dec 2013
Q3 2013 -375 -434 -726% 30 Sep 2013
Q2 2013 6.24K +6.18K +9276% 30 Jun 2013
Q1 2013 78.3 -14.2 -15.3% 31 Mar 2013
Q4 2012 43.9 31 Dec 2012
Q3 2012 59.8 30 Sep 2012
Q2 2012 66.6 30 Jun 2012
Q1 2012 92.5 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.